Perrigo Company PLC (NYSE:PRGO)
| 30.36 Delayed Data As of 4:00pm ET |  -0.10 / -0.33%Today’s Change | 26.81 Today|||52-Week Range 40.28 | -10.94% Year-to-Date |
PRGO Regular Dividend: PRGO will begin trading ex-dividend on 11/30/23 with a $0.273 dividend payable to shareholders of record as of 12/01/23.
Latest PRGO News | Press Releases
| Insider Buying Alert: EVP & CHRO Robert Willis Acquires Shares of Perrigo Co PLC Nov 28 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 30.46 |
| Today’s open | 30.60 |
| Day’s range | 30.11 - 30.60 |
| Volume | 882,078 |
| Average volume (3 months) | 1,502,681 |
| Market cap | $4.2B |
Data as of 4:00pm ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -19.98% |
| Earnings growth (this year) | +26.57% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +7.47% |
| P/E ratio | 379.4 |
| Price/Sales | 1.03 |
| Price/Book | 0.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRTXMirati Therapeutics ... | +0.12 | +0.21% |
| ALKSAlkermes Plc | +0.20 | +0.85% |
| ---- | ||
| ---- |
Data as of 4:00pm ET, 11/29/2023
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | $0.93 |
| Annual revenue (last year) | $4.5B |
| Annual profit (last year) | -$140.6M |
| Net profit margin | -2.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
